Pharmaceuticals and Medical Devices Agency Japan
E555156
The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority responsible for the review, approval, and safety monitoring of pharmaceuticals and medical devices.
Observed surface forms (2)
| Surface form | Occurrences |
|---|---|
| Pharmaceuticals and Medical Devices Agency of Japan | 1 |
| Pharmaceuticals and Medical Devices Agency | 0 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
government agency
ⓘ
independent administrative institution ⓘ regulatory agency ⓘ |
| abbreviation | PMDA NERFINISHED ⓘ |
| alsoKnownAs | PMDA Japan NERFINISHED ⓘ |
| cooperatesWith |
European Medicines Agency
NERFINISHED
ⓘ
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use NERFINISHED ⓘ Ministry of Health, Labour and Welfare NERFINISHED ⓘ U.S. Food and Drug Administration NERFINISHED ⓘ World Health Organization NERFINISHED ⓘ |
| country | Japan ⓘ |
| hasOfficialWebsite | https://www.pmda.go.jp ⓘ |
| headquartersLocation |
Chiyoda, Tokyo, Japan
NERFINISHED
ⓘ
Tokyo, Japan NERFINISHED ⓘ |
| jurisdiction | Government of Japan ⓘ |
| languageOfWorkOrName | Japanese ⓘ |
| legalForm | independent administrative institution of Japan ⓘ |
| mandate |
ensure quality, efficacy, and safety of medical devices in Japan
ⓘ
ensure quality, efficacy, and safety of pharmaceuticals in Japan ⓘ |
| nativeName | 医薬品医療機器総合機構 NERFINISHED ⓘ |
| parentOrganization | Ministry of Health, Labour and Welfare NERFINISHED ⓘ |
| performs |
benefit-risk assessment of medical products
ⓘ
regulatory science research ⓘ risk management of medical products ⓘ |
| regionServed | Japan ⓘ |
| regulates |
biopharmaceuticals
ⓘ
in vitro diagnostic medical devices ⓘ over-the-counter drugs ⓘ prescription drugs ⓘ |
| responsibleFor |
GCP inspections
ⓘ
GLP inspections ⓘ GMP inspections ⓘ adverse drug reaction assessment ⓘ adverse event reporting system ⓘ drug safety monitoring ⓘ medical device regulation ⓘ medical device safety monitoring ⓘ pharmaceutical regulation ⓘ pharmacovigilance ⓘ post-marketing surveillance ⓘ regulation of cellular and gene therapy products ⓘ regulation of regenerative medical products ⓘ review of clinical trial notifications ⓘ review of generic drug applications ⓘ review of medical device applications ⓘ review of new drug applications ⓘ |
| sector |
healthcare regulation
ⓘ
medical device regulation ⓘ pharmaceutical regulation ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
ICH Q9 Quality Risk Management
→
regionallyImplementedBy
→
Pharmaceuticals and Medical Devices Agency Japan
ⓘ
this entity surface form:
Pharmaceuticals and Medical Devices Agency of Japan